← The Wire
ARVNNasdaq
ARVINAS, INC.
Pharmaceutical Preparations · DE · CIK 1655759
Develops novel protein degraders using its PROTAC platform to treat debilitating diseases
red 8-K · 90d
$489M
Market cap
$8.29
Last close
+3.6%
1D
+7.1%
5D
955K
Volume
Price · last 39 sessions-23.1%
May 4L $6.98 · H $10.78Jun 29
186
Total filings
Jun 25, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 25, 20268-KExecutive ChangeJun 22, 20268-KCompany UpdateJun 16, 20268-KReg FD Disclosure · Company UpdateJun 2, 20268-KResults of OperationsMay 12, 20268-KMaterial Agreement · Reg FD DisclosureMay 12, 202610-Q10-QMay 11, 20268-KReg FD Disclosure · Company UpdateMay 1, 2026DEFA14ADEFA14AApr 29, 2026DEF 14ADEF 14AApr 29, 20268-KReg FD Disclosure · Company UpdateMar 18, 202610-K10-KFeb 24, 20268-KResults of OperationsFeb 24, 20268-KExecutive ChangeFeb 12, 20268-KReg FD Disclosure · Company UpdateDec 8, 202510-Q10-QNov 5, 20258-KResults of OperationsNov 5, 20258-KReg FD Disclosure · Company UpdateOct 24, 20258-KReg FD Disclosure · Company UpdateOct 20, 20258-KReg FD Disclosure · Company UpdateOct 6, 20258-KExit / Disposal Costs · Reg FD DisclosureSep 17, 20258-KReg FD Disclosure · Company UpdateAug 8, 202510-Q10-QAug 6, 20258-KResults of OperationsAug 6, 20258-KExecutive ChangeJul 9, 20258-KExecutive Change · Shareholder VoteJun 30, 20258-KReg FD Disclosure · Company UpdateJun 13, 20258-KExecutive ChangeJun 6, 20258-KCompany UpdateJun 6, 20258-KReg FD Disclosure · Company UpdateJun 2, 202510-Q10-QMay 1, 20258-KResults of Operations · Exit / Disposal CostsMay 1, 2025DEFA14ADEFA14AApr 29, 2025DEF 14ADEF 14AApr 29, 20258-KReg FD Disclosure · Company UpdateApr 28, 20258-KReg FD Disclosure · Company UpdateApr 4, 20258-KReg FD Disclosure · Company UpdateMar 11, 202510-K10-KFeb 11, 20258-KResults of OperationsFeb 11, 20258-KMaterial Agreement · Agreement TerminatedJan 22, 20258-KReg FD Disclosure · Company UpdateJan 10, 20258-KMaterial AgreementJan 6, 20258-KMaterial AgreementDec 16, 20248-KReg FD Disclosure · Company UpdateDec 10, 20248-KCompany UpdateNov 19, 202410-Q10-QOct 30, 20248-KResults of OperationsOct 30, 20248-KMaterial AgreementAug 20, 202410-Q10-QJul 30, 20248-KResults of OperationsJul 30, 20248-KExecutive ChangeJun 24, 20248-KMaterial AgreementJun 18, 20248-KExecutive ChangeJun 17, 20248-KShareholder VoteMay 30, 20248-KCompany UpdateMay 30, 20248-KReg FD Disclosure · Company UpdateMay 16, 202410-Q10-QMay 7, 20248-KResults of OperationsMay 7, 2024DEFA14ADEFA14AApr 16, 2024DEF 14ADEF 14AApr 16, 20248-KMaterial Agreement · Reg FD DisclosureApr 11, 20248-KExecutive ChangeMar 18, 202410-K10-KFeb 27, 20248-KResults of OperationsFeb 27, 20248-KExecutive ChangeFeb 20, 2024SC 13GSC 13GFeb 14, 2024SC 13GARVINAS, INC.Feb 14, 20248-KCompany UpdateJan 8, 20248-KReg FD Disclosure · Company UpdateDec 6, 20238-KMaterial Agreement · Equity IssuanceNov 27, 202310-Q10-QNov 7, 20238-KResults of OperationsNov 7, 20238-KReg FD Disclosure · Company UpdateOct 23, 202310-Q10-QAug 8, 20238-KResults of OperationsAug 8, 20238-KBylaw Amendment · Shareholder VoteJun 21, 20238-KReg FD Disclosure · Company UpdateJun 8, 202310-Q10-QMay 5, 20238-KResults of OperationsMay 5, 2023DEFA14ADEFA14AApr 28, 2023
Insider Activity
In the 90 days to Mar 18, 2026: 1 insider bought $268K · 6 sold $901K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 18, 2026 | Berkowitz NoahChief Medical Officer | Sell | 6,435 | $11.10 | $71K |
| Mar 6, 2026 | Morrison BriggsDirector | Buy | 20,000 | $13.40 | $268K |
| Feb 27, 2026 | Houston John GDirector | Sell | 18,822 | $13.24 | $249K |
| Feb 27, 2026 | Houston John GDirector | Sell | 11,787 | $13.14 | $155K |
| Feb 27, 2026 | Houston John GDirector | Sell | 4,688 | $13.24 | $62K |
| Feb 23, 2026 | Teel RandyPresident and CEO | Sell | 3,748 | $12.16 | $46K |
| Feb 23, 2026 | Cacace Angela MChief Scientific Officer | Sell | 2,571 | $12.16 | $31K |
| Feb 23, 2026 | Loomis David KChief Accounting Officer | Sell | 1,108 | $12.16 | $13K |
| Feb 23, 2026 | Teel RandyPresident and CEO | Sell | 1,038 | $12.16 | $13K |
| Feb 23, 2026 | Cacace Angela MChief Scientific Officer | Sell | 1,038 | $12.16 | $13K |
| Feb 13, 2026 | Berkowitz NoahChief Medical Officer | Sell | 5,685 | $11.89 | $68K |
| Feb 13, 2026 | Saik AndrewChief Financial Officer | Sell | 5,134 | $11.89 | $61K |
| Feb 13, 2026 | Cacace Angela MChief Scientific Officer | Sell | 4,592 | $11.89 | $55K |
| Feb 13, 2026 | Teel RandyPresident and CEO | Sell | 4,403 | $11.89 | $52K |
| Feb 13, 2026 | Loomis David KChief Accounting Officer | Sell | 1,016 | $11.89 | $12K |
| Nov 7, 2025 | Loomis David KChief Accounting Officer | Sell | 230 | $9.89 | $2K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance